MariMed, Inc. (MRMD)
0.0471
0.00 (0.00%)
USD |
OTCM |
Nov 20, 16:00
MariMed Enterprise Value : 104.20M for Nov. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 104.20M |
| November 19, 2026 | 104.97M |
| November 18, 2026 | 107.80M |
| November 17, 2026 | 108.41M |
| November 16, 2026 | 110.48M |
| November 13, 2026 | 113.58M |
| November 12, 2026 | 115.49M |
| November 11, 2026 | 115.29M |
| November 10, 2026 | 114.48M |
| November 09, 2026 | 115.65M |
| November 06, 2026 | 112.26M |
| November 05, 2026 | 111.71M |
| November 04, 2026 | 109.85M |
| November 03, 2026 | 104.55M |
| November 02, 2026 | 104.97M |
| October 30, 2026 | 105.94M |
| October 29, 2026 | 106.59M |
| October 28, 2026 | 106.55M |
| October 27, 2026 | 106.79M |
| October 26, 2026 | 106.27M |
| October 23, 2026 | 106.51M |
| October 22, 2026 | 107.80M |
| October 21, 2026 | 107.76M |
| October 20, 2026 | 107.60M |
| October 19, 2026 | 108.21M |
| Date | Value |
|---|---|
| October 16, 2026 | 109.02M |
| October 15, 2026 | 108.13M |
| October 14, 2026 | 109.42M |
| October 13, 2026 | 109.02M |
| October 12, 2026 | 110.52M |
| October 09, 2026 | 110.78M |
| October 08, 2026 | 110.88M |
| October 07, 2026 | 110.84M |
| October 06, 2026 | 111.85M |
| October 05, 2026 | 111.85M |
| October 02, 2026 | 113.07M |
| October 01, 2026 | 113.31M |
| September 30, 2026 | 113.47M |
| September 29, 2026 | 117.36M |
| September 28, 2026 | 116.76M |
| September 25, 2026 | 118.16M |
| September 24, 2026 | 117.16M |
| September 23, 2026 | 116.96M |
| September 22, 2026 | 116.64M |
| September 21, 2026 | 115.11M |
| September 18, 2026 | 116.60M |
| September 17, 2026 | 116.96M |
| September 16, 2026 | 115.95M |
| September 15, 2026 | 116.85M |
| September 14, 2026 | 118.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cencora, Inc. | 71.09B |
| Acme United Corp. | 301.55M |
| ANI Pharmaceuticals, Inc. | 1.741B |
| Cardinal Health, Inc. | 67.00B |
| Corcept Therapeutics, Inc. | 6.596B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.487M |
| Revenue (Quarterly) | 44.23M |
| Total Expenses (Quarterly) | 47.73M |
| EPS Diluted (Quarterly) | -0.0087 |
| Gross Profit Margin (Quarterly) | 20.84% |
| Profit Margin (Quarterly) | -7.88% |
| Earnings Yield | -82.59% |
| Normalized Earnings Yield | -83.01 |